National Foundation for Cancer Research – NFCR shared a post on LinkedIn:
“What happens when a pioneering oncologist and a next-generation immunotherapy researcher sit down to talk about the future of cancer care?
In the newest episode of All Things Cancer, NFCR President and CEO Dr. Sujuan Ba brings together Dr. Brian Leyland-Jones, longtime NFCR medical advisor, and Dr. Avery Posey, an NFCR-supported scientist at the University of Pennsylvania developing CAR-T therapies for solid tumors.
Together, they explore how far we’ve come – from chemotherapy to CRISPR – and how collaboration across generations is shaping what’s next in cancer research.
Listen now:
Proceed to the video attached to the post.
More posts featuring NFCR.